Mostrar el registro sencillo del ítem

dc.contributor.authorBergonti, M.*
dc.contributor.authorSpera, F.R.*
dc.contributor.authorFerrero, T.G.*
dc.contributor.authorNsahlai, M.*
dc.contributor.authorBonomi, A.*
dc.contributor.authorTijskens, M.*
dc.contributor.authorBoris, W.*
dc.contributor.authorSaenen, J.*
dc.contributor.authorHuybrechts, W.*
dc.contributor.authorMiljoen, H.*
dc.contributor.authorGonzález Juanatey, José Ramón *
dc.contributor.authorMartínez Sande, Jose Luis *
dc.contributor.authorVandaele, L.*
dc.contributor.authorWittock, A.*
dc.contributor.authorHeidbuchel, H.*
dc.contributor.authorValderrábano, M.*
dc.contributor.authorRodríguez Mañero, Moises *
dc.contributor.authorSarkozy, A.*
dc.date.accessioned2025-09-08T11:50:56Z
dc.date.available2025-09-08T11:50:56Z
dc.date.issued2023
dc.identifier.citationBergonti M, Spera FR, Ferrero TG, Nsahlai M, Bonomi A, Tijskens M, et al. Characterization of Atrial Substrate to Predict the Success of Pulmonary Vein Isolation: The Prospective, Multicenter MASH-AF II (Multipolar Atrial Substrate High Density Mapping in Atrial Fibrillation) Study. Journal of the American Heart Association. 2023;12(1):e027795.
dc.identifier.issn2047-9980
dc.identifier.otherhttps://portalcientifico.sergas.gal//documentos/63c390fab0644813d90264f8
dc.identifier.urihttp://hdl.handle.net/20.500.11940/21204
dc.description.abstractBackground Left atrial substrate may have mechanistic relevance for ablation of atrial fibrillation (AF). We sought to analyze the relationship between low-voltage zones (LVZs), transition zones, and AF recurrence in patients undergoing pulmonary vein isolation. Methods and Results We conducted a prospective multicenter study on consecutive patients undergoing pulmonary vein isolation-only approach. LVZs and transition zones (0.5-1 mV) were analyzed offline on high-density electroanatomical maps collected before pulmonary vein isolation. Overall, 262 patients (61±11 years, 31% female) with paroxysmal (130 pts) or persistent (132 pts) AF were included. After 28 months of follow-up, 73 (28%) patients experienced recurrence. An extension of more than 5% LVZ in paroxysmal AF and more than 15% in persistent AF was associated with recurrence (hazard ratio [HR], 4.4 [95% CI, 2.0-9.8], P<0.001 and HR, 1.9 [95% CI, 1.1-3.7], P=0.04, respectively). Significant association was found between LVZs and transition zones and between LVZs and left atrial volume index (LAVI) (both P<0.001). Thirty percent of patients had significantly increased LAVI without LVZs. Eight percent of patients had LVZs despite normal LAVI. Older age, female sex, oncological history, and increased AF recurrence characterized the latter subgroup. Conclusions In patients undergoing first pulmonary vein isolation, the impact of LVZs on outcomes occurs with lower burden in paroxysmal than persistent AF, suggesting that not all LVZs have equal prognostic implications. A proportional area of moderately decreased voltages accompanies LVZs, suggesting a continuous substrate instead of the dichotomous division of healthy or diseased tissue. LAVI generally correlates with LVZs, but a small subgroup of patients may present with disproportionate atrial remodeling, despite normal LAVI.
dc.description.sponsorshipThe study has been financially supported by an investigator-initiated research grant by Biosense Webster (Study ID - IIS-532) (M.R.M.).
dc.languageeng
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshHumans *
dc.subject.meshFemale *
dc.subject.meshMale *
dc.subject.meshAtrial Fibrillation *
dc.subject.meshProspective Studies *
dc.subject.meshPulmonary Veins *
dc.subject.meshTreatment Outcome *
dc.subject.meshHeart Atria *
dc.subject.meshCatheter Ablation *
dc.subject.meshRecurrence *
dc.titleCharacterization of Atrial Substrate to Predict the Success of Pulmonary Vein Isolation: The Prospective, Multicenter MASH-AF II (Multipolar Atrial Substrate High Density Mapping in Atrial Fibrillation) Study
dc.typeArtigo
dc.authorsophosBergonti, M.; Spera, F.R.; Ferrero, T.G.; Nsahlai, M.; Bonomi, A.; Tijskens, M.; Boris, W.; Saenen, J.; Huybrechts, W.; Miljoen, H.; González-Juanatey, J.R.; Martínez-Sande, J.L.; Vandaele, L.; Wittock, A.; Heidbuchel, H.; Valderrábano, M.; Rodríguez-Mañero, M.; Sarkozy, A.
dc.identifier.doi10.1161/jaha.122.027795
dc.identifier.sophos63c390fab0644813d90264f8
dc.issue.number1
dc.journal.titleJournal of the American Heart Association*
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario de Santiago::Cardioloxía
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario de Santiago::Cardioloxía
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario de Santiago::Cardioloxía
dc.page.initiale027795
dc.relation.projectIDBiosense Webster [IIS-532]
dc.relation.publisherversionhttps://doi.org/10.1161/jaha.122.027795
dc.rights.accessRightsopenAccess*
dc.subject.keywordAS Santiago
dc.subject.keywordCHUS
dc.subject.keywordAS Santiago
dc.subject.keywordCHUS
dc.subject.keywordAS Santiago
dc.subject.keywordCHUS
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)
dc.typesophosArtículo Original
dc.volume.number12


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 International
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 International